Ten large-cap stocks, including CRWV, COHR & AMZN, were the worst performers last week. Weak results, downgrades, and FTC ...

Justin Penik is breaking down the New York Giants win over the New York Jets in the MetLife bowl. This episode was brought to ...

In recent years, men’s health has shifted from being a quiet, private matter to an open conversation fueled by technology and ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

Recent health-related developments include Britain's decisions on the bioethanol industry, Berkshire Hathaway's new stake in ...

U.S. equities were mixed at midday following the release of the July retail sales report, which came in as expected.

The disclosure in a filing Thursday gave a much-needed boost to the beleaguered health insurance giant, which saw shares jump as much as 9.6% in post-market trading. In other news: Nike co-founder ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...

The US health sector is bustling with activity. Key developments include an FTC investigation into Hims & Hers' practices, ...

For more than a year, the Federal Trade Commission has been investigating Hims & Hers Health Inc.’s business practices, including whether it has made it too hard for customers to cancel subscriptions, ...